HYPERION DEFI, INC. (HYPD) Operating Margin
- Operating margin · 12 months: Value 314.33%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 314.33% | Operating income / revenue. Period ending 2026-06-30. $4.40M ÷ $1.40M × 100 ≈ 314.33% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 4.40M USD | Operating Income (Loss) |
| Revenue | 1.40M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | 908.06K USD | Research and Development Expense |
| Selling, general and administration | 15.54M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4.40M | $1.40M | (m) | $908.06K | $15.54M | 314.33% |
| 2026-03-31 | $-34.96M | $1.04M | (m) | $1.52M | $19.30M | -3351.68% |
| 2025-12-31 | $-46.72M | $813.46K | (m) | $1.91M | $17.18M | -5743.53% |
| 2025-09-30 | $-26.41M | $345.32K | (m) | $3.68M | $15.85M | -7647.11% |
| 2025-06-30 | $-38.17M | $44.44K | (m) | $6.78M | $16.99M | -85888.28% |
| 2025-03-31 | $-41.50M | $67.06K | (m) | $10.70M | (m) | -61885.23% |
| 2024-12-31 | $-48.74M | $57.34K | (m) | $14.46M | $14.33M | -85004.58% |
| 2024-09-30 | $-36.75M | $31.83K | (m) | $16.57M | (m) | -115461.33% |
| 2024-06-30 | $-35.94M | $31.41K | (m) | $16.67M | (m) | -114446.45% |
| 2024-03-31 | $-30.21M | (m) | (m) | $14.89M | (m) | (m) |
| 2023-12-31 | $-25.41M | $3.79K | (m) | $12.98M | (m) | -670885.82% |
| 2023-09-30 | $-23.31M | (m) | (m) | $11.11M | (m) | (m) |
| 2023-06-30 | $-24.02M | (m) | (m) | $11.41M | (m) | (m) |
| 2023-03-31 | $-25.18M | (m) | (m) | $12.19M | (m) | (m) |
| 2022-12-31 | $-26.91M | (m) | (m) | $13.38M | (m) | (m) |
| 2022-09-30 | $-18.37M | $10.00M | (m) | $14.13M | (m) | -183.69% |
| 2022-06-30 | $-17.06M | $10.00M | (m) | $13.80M | (m) | -170.64% |
| 2022-03-31 | $-14.72M | $12.00M | (m) | $13.90M | (m) | -122.70% |
| 2021-12-31 | $-12.90M | $14.00M | (m) | $14.51M | (m) | -92.17% |
| 2021-09-30 | $-20.22M | (m) | (m) | $14.68M | (m) | (m) |
| 2021-06-30 | $-19.41M | $6.00M | (m) | $14.58M | (m) | -323.51% |
| 2021-03-31 | $-19.67M | (m) | (m) | $13.88M | (m) | (m) |
| 2020-12-31 | $-19.79M | $2.00M | (m) | $13.26M | (m) | -989.46% |
| 2020-09-30 | $-20.87M | (m) | (m) | $13.24M | (m) | (m) |
| 2020-06-30 | $-20.47M | (m) | (m) | $13.08M | (m) | (m) |
| 2020-03-31 | $-20.83M | (m) | (m) | $13.73M | (m) | (m) |
| 2019-12-31 | $-21.31M | (m) | (m) | $14.10M | (m) | (m) |
| 2019-09-30 | $-22.20M | (m) | (m) | $14.90M | (m) | (m) |
| 2019-06-30 | $-21.83M | (m) | (m) | $14.19M | (m) | (m) |
| 2019-03-31 | $-19.78M | (m) | (m) | $13.03M | (m) | (m) |
| 2018-12-31 | $-17.26M | (m) | (m) | $11.12M | (m) | (m) |
| 2018-09-30 | $-13.24M | (m) | (m) | $8.58M | (m) | (m) |
| 2018-06-30 | $-9.80M | (m) | (m) | $6.66M | (m) | (m) |
| 2018-03-31 | $-7.46M | (m) | (m) | $5.00M | (m) | (m) |
| 2017-12-31 | $-5.13M | (m) | (m) | $3.82M | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $-3.53M | (m) | (m) | $2.97M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |